REGENERON PHARMACEUTICALS INC. - COMMON STOCK

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma

28 Apr 2025 07:01:41 By Nasdaq GlobeNewswire

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

28 Apr 2025 07:00:32 By Nasdaq GlobeNewswire

Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines

22 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

Regeneron Announces Investor Conference Presentations

21 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

18 Apr 2025 15:00:22 By Nasdaq GlobeNewswire

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

18 Apr 2025 11:15:32 By Nasdaq GlobeNewswire

EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications

17 Apr 2025 07:00:08 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

09 Apr 2025 09:45:11 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

08 Apr 2025 13:12:54 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

07 Apr 2025 09:45:03 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

04 Apr 2025 09:46:04 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

03 Apr 2025 16:08:52 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 Apr 2025 09:45:07 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

01 Apr 2025 14:45:14 By NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

31 Mar 2025 09:50:37 By NetDania Notify

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

28 Mar 2025 02:00:14 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

26 Mar 2025 09:46:28 By NetDania Notify

Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025

25 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 Mar 2025 14:10:05 By NetDania Notify

Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem

11 Mar 2025 21:32:16 By Nasdaq GlobeNewswire